Eric J Brown

Aprea Therapeutics, Inc.

NIH Rank #4309
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.3M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#4,309
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.3M across 3 grants · National rank #4309.

Top grants by award amount

Eric J Brown's NIH grant portfolio, ranked by award amount.

  • 5R44CA278078-02R44
    Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous ovarian cancer
    $1.1M
    award amount
  • 1R01CA285965-01R01
    Developing biomarkers of response for a new therapy in ovarian cancer
    $692.5K
    award amount
  • 5R01CA266645-02R01
    Effect of DNA repeat silencing on efficacy of ATRi in prostate cancer treatment
    $440.6K
    award amount

Affiliations

Institutions that have administered grants for Eric J Brown.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Aprea Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4309
  6. 2024
    Entered Top 25% Nationally
    Ranked #4309
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Eric J Brown.